-
26 September 2025 23:12:01
- Source: Sharecast
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||||||
|
a)
|
Name
|
Bharti Televentures UK Limited |
|||||||||
|
2
|
Reason for the notification
|
||||||||||
|
a)
|
Position/status
|
Person closely associated with Sunil Bharti Mittal, non-independent non-executive director |
|||||||||
|
b)
|
Initial notification /Amendment
|
Initial |
|||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||||||
|
a)
|
Name
|
BT Group plc |
|||||||||
|
b)
|
LEI
|
213800LRO7NS5CYQMN21 |
|||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in BT Group plc of 5p each
ISIN: GB0030913577
|
|||||||||
|
b)
|
Nature of the transaction
|
(1) Novation of existing cash-settled derivatives transactions relating to the Issuer's ordinary shares entered into by Bharti Televentures UK Limited from existing counterparties to new counterparty. (2) Pledge of Issuer ordinary shares to secure Bharti Televentures UK Limited obligations to new counterparty under the novated derivatives referred to in (1), replacing pledge to outgoing existing counterparties. The extent of Bharti Televentures UK Limited's overall interest in the Issuer's ordinary shares remains unaltered following the novation and pledge. |
|||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
150,000,000 ordinary shares of the issuer referenced by the novated derivatives.
N/A
|
|||||||||
|
e)
|
Date of the transaction
|
25 September 2025 |
|||||||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||||||||
Name of contact and telephone number for queries
Enquiries
|
Press office: |
|
||
|
Richard Farnsworth Jackie Bates |
Tel: +44 7734 776 317 Tel: +44 7496 691845 |
||
|
|
||
|
Investor relations: |
|
||
|
Nick Delfas |
Tel: 0800 389 4909 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.